2021 Q4 Form 10-K Financial Statement

#000156459022013025 Filed on March 31, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $6.058M $20.41M $7.013M
YoY Change -13.62% -4.6% -4.42%
Cost Of Revenue $2.543M $8.479M $2.871M
YoY Change -11.42% -2.49% 3.45%
Gross Profit $3.514M $11.94M $4.142M
YoY Change -15.14% -6.05% -9.21%
Gross Profit Margin 58.01% 58.47% 59.06%
Selling, General & Admin $4.152M $14.06M $3.610M
YoY Change 15.03% 3.2% -11.79%
% of Gross Profit 118.14% 117.83% 87.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.89K $67.64K $20.09K
YoY Change 3.98% -35.05% -33.37%
% of Gross Profit 0.59% 0.57% 0.49%
Operating Expenses $4.173M $14.13M $3.630M
YoY Change 14.97% 2.91% -11.94%
Operating Profit -$658.6K -$2.196M $512.1K
YoY Change -228.61% 113.59% 16.43%
Interest Expense -$30.67K -$78.23K -$19.32K
YoY Change 58.75% -17.61% -41.93%
% of Operating Profit -3.77%
Other Income/Expense, Net $342.2K $342.2K -$290.6K
YoY Change -217.73% -217.73% -115.01%
Pretax Income -$347.1K -$1.570M $202.1K
YoY Change -271.72% 11.08% -85.67%
Income Tax $5.000K $17.72K $7.650K
% Of Pretax Income 3.79%
Net Earnings -$352.1K -$1.588M $194.5K
YoY Change -281.05% 10.85% -86.12%
Net Earnings / Revenue -5.81% -7.78% 2.77%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$4.985K -$0.02 $2.769K
COMMON SHARES
Basic Shares Outstanding 70.32M
Diluted Shares Outstanding 70.32M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $553.2K $553.2K $1.187M
YoY Change -53.41% -53.41% 8.02%
Cash & Equivalents $553.2K $553.2K $1.187M
Short-Term Investments
Other Short-Term Assets $5.920K $5.920K $24.20K
YoY Change -75.54% -75.54% -39.27%
Inventory $8.736M $8.736M $6.981M
Prepaid Expenses
Receivables $3.529M $3.529M $4.428M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.82M $12.82M $12.62M
YoY Change 1.61% 1.61% -11.4%
LONG-TERM ASSETS
Property, Plant & Equipment $7.251K $7.250K $17.79K
YoY Change -59.24% -59.25% -45.49%
Goodwill $1.973M $1.973M
YoY Change 0.0% 0.0%
Intangibles $1.317M $1.138M
YoY Change 15.75% -5.68%
Long-Term Investments $1.670M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.480M $5.480M $4.798M
YoY Change 14.21% 14.21% 15.99%
TOTAL ASSETS
Total Short-Term Assets $12.82M $12.82M $12.62M
Total Long-Term Assets $5.480M $5.480M $4.798M
Total Assets $18.30M $18.30M $17.42M
YoY Change 5.08% 5.08% -5.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.462M $4.462M $3.237M
YoY Change 37.85% 37.85% 17.57%
Accrued Expenses $2.898M $2.898M $2.585M
YoY Change 12.12% 12.12% -21.74%
Deferred Revenue
YoY Change
Short-Term Debt $2.583M $2.583M $1.425M
YoY Change 81.28% 81.28% -25.11%
Long-Term Debt Due $0.00 $0.00 $2.240K
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $10.14M $9.942M $7.248M
YoY Change 39.93% 37.17% -8.92%
LONG-TERM LIABILITIES
Long-Term Debt $200.0K $200.0K $347.8K
YoY Change -42.49% -42.49%
Other Long-Term Liabilities $11.59M $11.59M $11.94M
YoY Change -2.87% -2.87% 2.5%
Total Long-Term Liabilities $11.79M $11.79M $12.28M
YoY Change -3.99% -3.99% 5.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.14M $9.942M $7.248M
Total Long-Term Liabilities $11.79M $11.79M $12.28M
Total Liabilities $21.74M $21.74M $19.53M
YoY Change 11.29% 11.29% -0.36%
SHAREHOLDERS EQUITY
Retained Earnings -$5.616M -$4.028M
YoY Change 39.42% 55.18%
Common Stock $2.184M $1.915M
YoY Change 14.04% 39.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.432M -$3.432M -$2.113M
YoY Change
Total Liabilities & Shareholders Equity $18.30M $18.30M $17.42M
YoY Change 5.08% 5.08% -5.23%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$352.1K -$1.588M $194.5K
YoY Change -281.05% 10.85% -86.12%
Depreciation, Depletion And Amortization $20.89K $67.64K $20.09K
YoY Change 3.98% -35.05% -33.37%
Cash From Operating Activities -$2.010M -$1.778M -$226.4K
YoY Change 787.61% -851.45% -371.63%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 797.7K 1.144M -125.0K
YoY Change -738.17% -995.55%
NET CHANGE
Cash From Operating Activities -2.010M -1.778M -226.4K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 797.7K 1.144M -125.0K
Net Change In Cash -1.212M -634.3K -351.4K
YoY Change 244.91% -819.55% -616.5%
FREE CASH FLOW
Cash From Operating Activities -$2.010M -$1.778M -$226.4K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$2.010M -$1.778M -$226.4K
YoY Change 787.61% -923.69% -329.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y11M1D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M23D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y7M24D
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
498261
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
787766
CY2021Q4 fzmd Allowance For Inventories Current
AllowanceForInventoriesCurrent
2491183
CY2020Q4 fzmd Allowance For Inventories Current
AllowanceForInventoriesCurrent
3077728
CY2021Q4 fzmd Allowance For Long Term Receivable Non Current
AllowanceForLongTermReceivableNonCurrent
3355391
CY2020Q4 fzmd Allowance For Long Term Receivable Non Current
AllowanceForLongTermReceivableNonCurrent
2615834
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
150000
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
150000
CY2020Q4 fzmd Paycheck Protection Program Current
PaycheckProtectionProgramCurrent
361400
CY2020Q4 fzmd Economic Injury Disaster Loan Current
EconomicInjuryDisasterLoanCurrent
2241
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2432770
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
913352
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9942479
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7248319
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
200000
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
200000
CY2020Q4 fzmd Economic Injury Disaster Loan Noncurrent
EconomicInjuryDisasterLoanNoncurrent
147759
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11593832
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11936000
CY2021Q4 us-gaap Liabilities
Liabilities
21736311
CY2020Q4 us-gaap Liabilities
Liabilities
19532078
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72895793
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72895793
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73124458
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73124458
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
728958
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
731245
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1455422
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1184222
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5616199
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4028308
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3431819
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-2112841
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18304492
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17419237
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20414268
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21398936
CY2021 fzmd Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
342168
CY2020 fzmd Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
-290635
CY2021 fzmd Gain Loss On Payroll Protection Program Loans Extinguishment
GainLossOnPayrollProtectionProgramLoansExtinguishment
361400
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1570168
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1413502
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1587891
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70321566
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70221566
CY2020 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
553184
CY2020 fzmd Franchise Tax Accrual
FranchiseTaxAccrual
11397
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-2112841
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
257913
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11000
CY2020 us-gaap Profit Loss
ProfitLoss
-1432495
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
104143
CY2020 fzmd Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
-290635
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
553184
CY2020 fzmd Provision For Discounts On Long Term Accounts Receivable
ProvisionForDiscountsOnLongTermAccountsReceivable
1887836
CY2020 fzmd Provision For Bad Debts And Discounts
ProvisionForBadDebtsAndDiscounts
172488
CY2020 fzmd Provision For Slow Moving And Obsolete Inventory
ProvisionForSlowMovingAndObsoleteInventory
-728002
CY2021 fzmd Gain Loss On Payroll Protection Program Loan Extinguishment
GainLossOnPayrollProtectionProgramLoanExtinguishment
361400
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-649269
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
483738
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-729567
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
236654
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20757
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20757
CY2021 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-913352
CY2020 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-839149
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1602476
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-15647
CY2020 fzmd Increase Decrease In Long Term Accounts Receivable
IncreaseDecreaseInLongTermAccountsReceivable
2632698
CY2021 fzmd Net Payment Proceeds On Senior Secured Revolving Credit Facility
NetPaymentProceedsOnSeniorSecuredRevolvingCreditFacility
2432770
CY2021 fzmd Payments For Senior Secured Revolving Credit Facility
PaymentsForSeniorSecuredRevolvingCreditFacility
236358
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11000
CY2020 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
200000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-634268
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
88148
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1099310
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
553190
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1187458
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19581
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
20000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
42830
CY2020 us-gaap Interest Paid Net
InterestPaidNet
62866
CY2021 fzmd Percentage Of Common Stock Issued
PercentageOfCommonStockIssued
0.614
CY2021 fzmd Percentage Of Common Stock Outstanding
PercentageOfCommonStockOutstanding
0.614
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in accordance with generally accepted accounting principles in the United States of America (GAAP), requires the Company’s management to make estimates and assumptions that affect the Company’s reported amounts in the consolidated financial statements.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Actual results could differ from those estimates. Significant estimates on the accompanying consolidated financial statements include the allowances for doubtful accounts, valuation of inventories, the Company’s effective income tax rate and the fair value calculations of stock-based compensation, goodwill, finite lived intangibles and the earn-out liability. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p>
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
594536
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
761671
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassification</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long term accounts receivable, net of allowance was previously reported as a component of current assets as accounts receivable, net of allowance, in the Company’s accompanying consolidated balance sheets. Long term accounts receivable reflects Cases where the patient has obtained a letter of protection, (“LOP”). A LOP is a contract that provides that the medical providers will be paid from any proceeds received from settlement of litigation of the underlying cause of action with respect to the event that necessitated medical goods and services. Once the medical provider receives payment, then the medical provider pays the Company’s invoice which payment is generally greater than 365 days from date of service. The LOP provides medical providers with greater certainty of full payment. This reclassification had no effect on the previously reported total assets or net loss.   </p>
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-342168
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11936000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11593832
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-290635
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11936000
CY2021Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2021Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1317341
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1138080
CY2021Q4 us-gaap Goodwill
Goodwill
1972886
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20414268
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21398936
CY2020Q4 us-gaap Goodwill
Goodwill
1972886
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
57097
CY2021 fzmd Fully Depreciated Assets Retired
FullyDepreciatedAssetsRetired
29669
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1496557
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20249
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49918
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12998
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32127
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7251
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17791
CY2021 us-gaap Depreciation
Depreciation
10540
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1260199
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
179216
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
122119
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
129318
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
129318
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
122752
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
50532
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
50530
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
130511
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
612961
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1495000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.90
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
210459
CY2021Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
2246892
CY2020Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
1816546
CY2021 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2017-12-31
CY2021 fzmd Operating Lease Requires Monthly Payments
OperatingLeaseRequiresMonthlyPayments
14000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7425
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7425
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
720
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15570
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2595000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.65
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
56000
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
100000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.11
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
150000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
600000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1745000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.86
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1522
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3736
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
200323
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
17723
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
18993
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
17723
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
18993
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17723
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18993
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
786751
CY2021Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
104635
CY2020Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
165431
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
555936
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
480774
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
523131
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
588966
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1244
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5083
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2447215
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2027005
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
198801
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
206723
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1816546
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1529584
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
430346
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
286962
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2246892
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1816546
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021 fzmd Effective Income Tax Rate Reconciliation Gain On Paycheck Protection Loan
EffectiveIncomeTaxRateReconciliationGainOnPaycheckProtectionLoan
0.045
CY2020 fzmd Effective Income Tax Rate Reconciliation Gain On Paycheck Protection Loan
EffectiveIncomeTaxRateReconciliationGainOnPaycheckProtectionLoan
0.000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2246892
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6010806
CY2021 fzmd Net Operating Loss Carryforwards Earliest Expiration Year
NetOperatingLossCarryforwardsEarliestExpirationYear
2021
CY2021 fzmd Net Operating Loss Carryforwards Latest Expiration Year
NetOperatingLossCarryforwardsLatestExpirationYear
2037
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.042
CY2021 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.000
CY2020 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.008
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.013
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.258
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.256
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.011
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.017
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.011
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.017

Files In Submission

Name View Source Status
0001564590-22-013025-index-headers.html Edgar Link pending
0001564590-22-013025-index.html Edgar Link pending
0001564590-22-013025.txt Edgar Link pending
0001564590-22-013025-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fzmd-10k_20211231.htm Edgar Link pending
fzmd-10k_20211231_htm.xml Edgar Link completed
fzmd-20211231.xsd Edgar Link pending
fzmd-20211231_cal.xml Edgar Link unprocessable
fzmd-20211231_def.xml Edgar Link unprocessable
fzmd-20211231_lab.xml Edgar Link unprocessable
fzmd-20211231_pre.xml Edgar Link unprocessable
fzmd-ex1041_238.htm Edgar Link pending
fzmd-ex1043_239.htm Edgar Link pending
fzmd-ex211_12.htm Edgar Link pending
fzmd-ex231_237.htm Edgar Link pending
fzmd-ex311_11.htm Edgar Link pending
fzmd-ex312_7.htm Edgar Link pending
fzmd-ex321_8.htm Edgar Link pending
g2w1phncwh5o000001.jpg Edgar Link pending
gd45zayubk2c000001.jpg Edgar Link pending
gd45zayubk2c000002.jpg Edgar Link pending
gniuqmlh0x4s000001.jpg Edgar Link pending
gsoahncmszfo000001.jpg Edgar Link pending
gsoahncmszfo000002.jpg Edgar Link pending
gsoahncmszfo000003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending